Drug Trial Radar · NCT02065700
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants
Last checked: Nov 19, 2026Latest source record: Jun 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
739
Actual
Start
Feb 25, 2014
Primary completion
Jan 19, 2023
Study completion Jan 19, 2023
Sponsor
- Lead sponsor
- Lakefront Biotherapeutics NVIndustry
- Sponsor type
- Industry
- Collaborators
- Gilead Sciences
- First posted
- Feb 19, 2014
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study was to evaluate the long-term safety and tolerability of filgotinib (formerly GLPG0634) for the treatment of rheumatoid arthritis. Participants were enrolled in this open-label long-term follow-up study after they had completed one of the two core studies, GLPG0634-CL-203 (DARWIN1) (NCT01888874) or GLPG0634-CL-204 (DARWIN2) (NCT01894516), and were evaluated for any side effects that might have occured (long-term safety and tolerability) when taking filgotinib. During the course of the study, participants were also examined for long-term effects of filgotinib administration on disease activity (efficacy), participant's disability, fatigue, and quality of life.
Conditions
- Rheumatoid Arthritis
Interventions
FilgotinibDrug
Administered as Oral Tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Experiencing Treatment-Emergent Adverse EventsTime frame: From First dose to Week 437
Locations
111 sites in 22 countries. Site status is shown where the registry gives one.
Arthro, Arthritis Care & Research
Gilbert, Arizona
Arizona Arthritis & Rheumatology Research PLLC
Mesa, Arizona
C.V. Mehta MD Medical Corp.
Hemet, California
Desert Medical Advances
Palm Desert, California
RASF Clinical Research Center
Boca Raton, Florida
Millenium Research
Ormond Beach, Florida
Lovelace Scientific Resources
Venice, Florida
Springfield Clinic
Springfield, Illinois
Klein and Associates MD, PA
Hagerstown, Maryland
Physicians East
Greenville, North Carolina
Health Research of Oklahoma
Oklahoma City, Oklahoma
Low County Rheumatology PA
Charleston, South Carolina
West Tennessee Research Institute
Jackson, Tennessee
Austin Rheumatology Research PA
Austin, Texas
Pioneer Research Solutions Inc
Houston, Texas
Atencion Integral en Reumatologa
Buenos Aires, Argentina
CER Intituto Medico
Buenos Aires, Argentina
Organizacion Medica de Investigaciones (OMI)
Buenos Aires, Argentina
Instituto Reumatologico Strusberg
Córdoba, Argentina
CIMeL Centro dee Investigacion Medico Lanus
Lanus, Argentina
Instituto CAICI
Rosario, Argentina
Instituto de Asistencia Reumatologia Integral - IARI
San Fernando, Argentina
Centro Médico Privado de Reumatologia
San Miguel de Tucumán, Argentina
Princess Alexandra Hospital
Woolloongabba, Australia
Flinders Medical Centre
Bedford Park, Flinders Drive, South Australia, Australia
Monash Medical Centre
Clayton, Victoria, Australia
Cliniques Universitaires St-Luc
Brussels, Belgium
UZ Leuven
Leuven, Belgium
University "Multiprofile Hospital for Active Treatment - Kaspela" LTD
Plovdiv, Bulgaria
Multiprofile Hospital for Active Treatment - Ruse
Rousse, Bulgaria
Diagnostic Consultative Center "Sveta Anna" LTD
Sofia, Bulgaria
National Multiprofile Transport Hospital "Tsar Boris III," Sofia, Clinical of Internal Diseases
Sofia, Bulgaria
University Multiprofile Hospital for Active Treatment "SV. Ivan Rilski" EAD, Sofia, Rheumatology Clinic
Sofia, Bulgaria
Hospital Regional "Guillermo Grant Benavente"
Santiago, Chile
Prosalud
Santiago, Chile
Someal SA
Santiago, Chile
Centro de Investigacion Clinica del Sur
Temuco, Chile
Consulta Privada Dra. Ponce
Temuco, Chile
Circaribe S.A.S
Barranquilla, Colombia
Centro de Investigacion en Reumatologia y Especialidades Medicas (CIREEM)
Bogotá, Colombia
Showing 40 of 111 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.